SCHEMBL19620527

SCHEMBL19620527

NC1=C(OSCc2ccccc2)C(=O)C(c2ccc(F)cc2F)O1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
GRM5 P41594 1/20 0.33
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
HTR2B P41595 1/20 0.32
MAPT P10636 2/20 0.32
HPGD P15428 1/20 0.32
GSK3B P49841 1/20 0.31
ADK P55263 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
DAO P14920 2/20 0.31
KDM4E B2RXH2 1/20 0.31
POLB P06746 1/20 0.31
ATM Q13315 1/20 0.31
CTSB P07858 1/20 0.31
MAOB P27338 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19620624 0.91 MEN1 (0.37) ALDH1A1CYP1A2CYP3A4CYP2C19GRM5
SCHEMBL19620451 0.89 GPBAR1 (0.36) CYP1A2CYP3A4CYP2C19HTR2AHTR2C
SCHEMBL19620717 0.89 CYP1A2 (0.33) CYP1A2CYP3A4CYP2C19GSK3BADK
SCHEMBL19620578 0.89 HTR2A (0.34) CYP1A2CYP3A4CYP2C19GRM5HTR2A
SCHEMBL19620625 0.89 CYP1A2 (0.34) ALDH1A1CYP1A2CYP3A4CYP2C19HTR2C
SCHEMBL19620515 0.87 CYP1A2 (0.33) CYP1A2CYP3A4CYP2C19GSK3BADK
SCHEMBL19620507 0.85 KDM4E (0.39) ALDH1A1GRM5MAPTMEN1KMT2A
SCHEMBL19620526 0.85 HTR2C (0.33) CYP1A2CYP3A4CYP2C19GRM5HTR2C
SCHEMBL19620514 0.84 KDM1A (0.33) ALDH1A1CYP1A2CYP3A4CYP2C19MAPT
SCHEMBL19620542 0.84 POLB (0.42) MAPTGSK3BADKMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3345596-A2 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2018-07-11 EP disclosed
EP-2897607-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2017-11-22 EP disclosed